SARS-CoV-2 Midnight Scheme Update![Matt Parker]()
Introduction This blog post will explain the changes we are making to the primer scheme naming in…
April 15, 2022
3 min
#workflows 72
EPI2ME Labs 22.03.01 Release![Stephen Rudd]()
Dear Nanopore Community This week the EPI2ME Labs team is delighted to release a new workflow,
wf…
March 09, 2022
1 min
EPI2ME Labs 22.02.01 Release![Stephen Rudd]()
Dear Nanopore Community, We are pleased to introduce an update to our EPI2ME Labs product that now…
February 09, 2022
2 min
Nextflow and Jupyter Labs![Stephen Rudd]()
We are pleased to introduce an update to our EPI2ME Labs product that now
includes the functionality…
February 09, 2022
2 min
EPI2ME Labs 22.01.01 Release![Stephen Rudd]()
Dear Nanopore Community, This Wednesday we have a trio of announcements; these include a new…
January 26, 2022
2 min
SARS-CoV-2 Midnight Analysis![Matt Parker]()
Introduction I wanted to write a blog post about SARS-CoV-2 sequencing data analysis to achieve two…
January 24, 2022
6 min
Related Links
© 2020 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.